
The European Commission has prepared the legal groundwork to disburse the first tranche of a €90 billion ($104.5 billion) loan for war-torn Ukraine that remains blocked amid resistance from Hungarian Prime Minister Viktor Orbán.
"We will deliver on the €90 billion loan to Ukraine," European Commission President Ursula von der Leyen stressed on Wednesday.
Russia-friendly Orbán has vetoed the loan as his party is facing a tough parliamentary election later this month. At a summit last month, several EU leaders were hopeful that Orbán will change his course after the election.
The commission has sent capitals a bill that requires unanimous approval to start disbursing the loan.
"With this we send a clear message: the commission stands ready to move forward," von der Leyen said.
Under the plans, €45 billion are to be disbursed in 2026, of which €16.7 billion are earmarked for budgetary assistance and €28.3 billion for improving Ukraine's defence industrial capacities with a focus on drone production.
"The budgetary support will be underpinned with strong conditions related to the rule of law, fight against corruption, economic resilience and sustainability," the commission said.
LATEST POSTS
- 1
Irish defence minister's trip to Lebanon cancelled - 2
In the background: Visiting Notable Film Areas All over the Planet - 3
From Exemplary to Current: Famous Rings Available - 4
Hyundai Is Keeping the i30 Alive While America Keeps Losing Cars Like It - 5
One lightly wounded after Iranian missile barrage targets northern Israel
Investigate the Excellence of Professional flowerbeds: A Virtual Local escort
Vehicle Lovers' Decision: Purchase A Reasonable Vehicle
Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist
Instructions to Distinguish the Wellbeing Dangers Related with 5G Pinnacles
Rubble, mud and hair: How to rebuild a home in Gaza
Holyvolt And Wildcat Could Help The West Reclaim Battery Leadership
Dominating the Remote Work Way of life: Individual Systems
They grew up with 'almond moms.' Now, they dread going home for the holidays.
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths













